Virtual Investor is a leading platform providing investors with direct access to innovative companies, management teams and thought leaders.

Upcoming Live Events

Covered Companies

Covered Companies

Series

CEO Connect

Featuring: Autonomix Medical
May 13, 2025

Brad Hauser, CEO of Autonomix Medical, Inc. Outlines Follow-On Expansion Study Expected to Begin in Q2 2025, Potentially Doubling  Addressable Market

What This Means

Featuring: CNS Pharmaceuticals
May 13, 2025

CNS Pharmaceuticals Acquires Orphan Drug Designation for Novel, Late Stage Abeotaxane, TPI 287
Company advancing plans to develop TPI 287, a novel, late stage abeotaxane that appears to cross the blood-brain barrier and has published clinical efficacy data in glioblastoma multiforme (GBM)

KOL Connect

Featuring: Veru
May 8, 2025

Moderated discussion with preeminent obesity expert Louis J. Aronne, MD, FACP and Mitchell Steiner, M.D., F.A.C.S, President, CEO, and Founder of Veru

What This Means

Featuring: GRI Bio
May 8, 2025

Marc Hertz, President and CEO of GRI Bio discusses Interim Biomarker Data Demonstrating Positive Trend Towards Anti-Fibrotic Effect of GRI-0621 in First Twelve Patients of Ongoing Phase 2a Study in Idiopathic Pulmonary Fibrosis (“IPF”)

What This Means

Featuring: Autonomix
May 1, 2025

Dr. Robert Schwartz, Chief Medical Officer of Autonomix, discusses key learnings from initial trial phase (“POC 1”) where clinically meaningful pain reduction was demonstrated

Outlines Company’s plans to initiate market expansion study (“POC 2”) into additional visceral cancers and earlier stage pancreatic cancer, expected to begin Q2 2025

What This Means

Featuring: SENTI Bio
May 1, 2025

Kanya Rajangam, MD, PhD, President, Head of R&D and Chief Medical Officer of Senti Bio discusses the positive data from lead program, SENTI-202, recently presented at the American Association for Cancer Research (AACR) Annual Meeting 2025

Past Events

Past Events

Join Us

Sign up for email alerts to stay up-to-date on the latest Virtual Investor events


By submitting this form, you are consenting to receive marketing emails from: Virtual Investor. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

If you are interested in joining our roster of covered companies and participating in our events, sign up here: